Log In
Print this Print this

levorphanol extended release (LevoCap ER) (REL-1015) (formerly TQ-1020)

  Manage Alerts
Collapse Summary General Information
Company Relmada Therapeutics Inc.
DescriptionOnce-daily, extended-release levorphanol in an abuse deterrent drug delivery system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat moderate to severe chronic pain; Treat pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today